Let HORIZONS HCC be your compass in navigating the complexities and latest developments in HCC patient care.
Sign up to receive our email updates for the latest news, resources, and educational materials.
SIGN UPform open in a popupSign up to receive our email updates for the latest news, resources, and educational materials.
SIGN UPform open in a popupWELCOME TO HORIZONS HCCastrazeneca page opens in the new tab
This website is intended to provide healthcare professionals practicing in the United States access to scientifically balanced, evidence-based, peer-led information, and professional resources to support the management of hepatocellular carcinoma. The dissemination of this information may be subject to different medical and regulatory requirements in other countries. This information is provided for educational purposes only. It is not intended for use in the diagnosis or treatment of individual patients.
Are you a healthcare professional practicing in the United States?
No, take me to AstraZeneca.com
What is an AstraZeneca authorized person?
This website is only intended for healthcare professionals practicing in the United States and authorized AstraZeneca personnel. AstraZeneca US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge. US Field Sales personnel should not access or browse this site. None of the content of this site should be directly linked or distributed without approval.
Thank you for submitting your Medical Follow-Up Request.
The information you submitted will be governed by our privacy policy and you will be contacted in due course.
HORIZONS HCC content will soon be heading your way.
If you no longer want to receive health-related materials, call 1-800-236-9933. Please visit www.azprivacy.astrazeneca.com to review our Privacy Notice. AstraZeneca will not knowingly collect, use, or disclose personally identifiable information from a minor under the age of 18. You must be 18 or older and a resident of the United States to subscribe.